| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ioannis Papassotiriou | |
| Konstantinos I Gourgoulianis | |||
| Maria Kechagia | |||
| P2860 | cites work | Proteoglycan form and function: A comprehensive nomenclature of proteoglycans | Q21710680 |
| Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1 | Q24291650 | ||
| Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity | Q24291764 | ||
| Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate | Q28257965 | ||
| Matrix proteoglycans: from molecular design to cellular function | Q28284300 | ||
| The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 | ||
| Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
| Heparan sulphate proteoglycans fine-tune mammalian physiology | Q29619329 | ||
| Loss of Endocan tumorigenic properties after alternative splicing of exon 2. | Q33315465 | ||
| Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching | Q33531069 | ||
| Adult respiratory distress syndrome - an update | Q33609809 | ||
| Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review | Q33870787 | ||
| Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. | Q33920795 | ||
| Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome | Q34012386 | ||
| Endothelial cell specific molecule-1--a newly identified protein in adipocytes. | Q34201843 | ||
| Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome | Q34258088 | ||
| ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. | Q34388585 | ||
| Endocan expression and relationship with survival in human non-small cell lung cancer | Q34555793 | ||
| The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology | Q34616197 | ||
| Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury | Q35212825 | ||
| Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions | Q35533253 | ||
| Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. | Q36259829 | ||
| Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. | Q36383938 | ||
| Pathophysiology of acute lung injury and the acute respiratory distress syndrome | Q36565892 | ||
| State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective | Q36571984 | ||
| Clinical implications for vascular endothelial growth factor in the lung: friend or foe? | Q36625050 | ||
| Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea | Q36840271 | ||
| Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis | Q36868721 | ||
| The endothelium in acute lung injury/acute respiratory distress syndrome | Q37057202 | ||
| Lower serum endocan levels are associated with the development of acute lung injury after major trauma | Q37215391 | ||
| Correlation between expression and differentiation of endocan in colorectal cancer | Q37316926 | ||
| ICAM-1: getting a grip on leukocyte adhesion | Q37387166 | ||
| Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders | Q37396389 | ||
| Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research | Q37780042 | ||
| Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? | Q37894728 | ||
| Adhesion molecules and inflammatory injury. | Q38308430 | ||
| Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity | Q38338617 | ||
| Endocan, a potential prognostic and diagnostic biomarker of acute leukemia | Q38984236 | ||
| Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features | Q39285472 | ||
| Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan | Q39431959 | ||
| Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans | Q39579344 | ||
| Endocan expression and localization in human glioblastomas | Q39848718 | ||
| The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia. | Q39920733 | ||
| Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. | Q40158663 | ||
| Overexpression of endocan induces tumor formation. | Q40629537 | ||
| Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection | Q40865545 | ||
| Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis | Q42475632 | ||
| Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan | Q43004362 | ||
| Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma | Q43183910 | ||
| Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions | Q43211297 | ||
| Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking | Q43544835 | ||
| von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome | Q43929614 | ||
| Endocan expression correlated with poor survival in human hepatocellular carcinoma | Q44125824 | ||
| Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome | Q44500521 | ||
| Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis | Q44657676 | ||
| Soluble form of P-selectin in plasma is elevated in acute lung injury | Q45068708 | ||
| Circulating ICAM-1 is increased in septic shock | Q45083634 | ||
| Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. | Q45539082 | ||
| Vascular dysfunction in chronic obstructive pulmonary disease. | Q45960606 | ||
| Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. | Q46943755 | ||
| ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis | Q47703606 | ||
| Abnormalities of the bronchial arteries in asthma. | Q50712065 | ||
| The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy. | Q51063519 | ||
| Expression of adhesion molecules in allergic lung diseases. | Q51719979 | ||
| Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism. | Q53095414 | ||
| Airway mucosal blood flow in bronchial asthma. | Q54132346 | ||
| Expression of ICAM-1, VCAM-1, and LFA-1 in adenocarcinoma of the lung with observations on the expression of these adhesion molecules in non-neoplastic lung tissue. | Q54402701 | ||
| Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. | Q54425814 | ||
| Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD | Q57552029 | ||
| Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease | Q60155038 | ||
| Clinical, functional and biochemical changes during recovery from COPD exacerbations | Q61510783 | ||
| Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt | Q64380808 | ||
| Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. | Q64964475 | ||
| HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis | Q72231405 | ||
| Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain | Q73119221 | ||
| Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer | Q73259688 | ||
| Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions | Q73294124 | ||
| [Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease] | Q73360470 | ||
| Increased vascularity of the bronchial mucosa in mild asthma | Q73528703 | ||
| Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome | Q77220356 | ||
| Inflammatory changes, recovery and recurrence at COPD exacerbation | Q79362620 | ||
| Molecular signatures in biopsy specimens of lung cancer | Q79934103 | ||
| Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD | Q81516504 | ||
| Endocan, a new endothelial marker in human sepsis | Q82313893 | ||
| Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia | Q83063416 | ||
| Expression and distribution of endocan in human tissues | Q83990341 | ||
| Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia | Q86495944 | ||
| Serum endocan levels as a marker of disease activity in patients with Behçet disease | Q86620487 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| respiratory system | Q7891 | ||
| respiratory disease | Q3286546 | ||
| carbohydrate | Q11358 | ||
| neoplasm protein | Q66894191 | ||
| P304 | page(s) | 3179-3187 | |
| P577 | publication date | 2016-12-12 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Endocan and the respiratory system: a review | |
| P478 | volume | 11 |
| Q64075792 | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
| Q58107618 | Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells through ESM1 Signalling |
| Q64070314 | Identification of ESM1 overexpressed in head and neck squamous cell carcinoma |
| Q58563180 | Serum endocan levels in patients with stable COPD |
| Q59793529 | The association of elevated circulating endocan levels with lung function decline in COPD patients |
Search more.